Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia 5Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Unspecified Adult Solid Tumor, Protocol Specific 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Lymphoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 21Fluorouracil 20Leucovorin 19Capecitabine 18Irinotecan 13Radiotherapy 8Bevacizumab 7Cetuximab 6Folfox protocol 4cediranib 2Radiation 2Psychiatric Rehabilitation 2Octreotide 2Cisplatin 2Chemoradiotherapy 2tipifarnib 1pertuzumab 1olaparib 1mercaptoundecahydrododecaborate 1eniluracil 1durvalumab 1brivanib 1alpha-Tocopherol 1Watchful Waiting 1Vitamin E 1Trastuzumab 1Tegafur 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Rectal Neoplasms × Immunologic Techniques × Clear all
NCT00897754 2017-05-19

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Eastern Cooperative Oncology Group

Completed
200 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡